The willingness to accept the coronavirus disease 2019 (COVID-19) vaccine and reasons for hesitancy in Hong Kong.
Lenvatinib mesylate by Eisai for Metastatic Biliary Tract Cancer: Likelihood of Approval
Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug